Job Description

Role and Responsibilities:

We are seeking an experienced talented scientist to join the Quantitative Pharmacology and Pharmacometrics \xe2\x80\x93 Immune/Oncology (QP2-IO) team in the role of Senior Director. QP2-IO team is part of the Global Clinical Development organization and has oversight over drug-development aspects related to clinical pharmacology and pharmacometrics of oncology drugs from nomination of drug candidate for development to registration. Our Senior Directors are considered experts in the field of quantitative drug development and possess a deep, integrated understanding of the strategic components involved in drug development. The successful candidate will have a deep understanding of both quantitative drug development and the strategic considerations involved in producing effective oncology drugs.

In their role as Senior Director, this individual will serve as the face of the QP2-IO team and collaborate with other teams to design and implement strategies for driving the development of oncology drug candidates. Their responsibilities will encompass overseeing the entire drug development process, from the early stages to achieving regulatory approval, with a focus on effective execution and successful implementation of these strategies. The Senior Director will design and execute quantitative analyses for individual compounds and across multiple development programs. They will also work to develop quantitative strategies and evaluate new modeling techniques to expedite go no/go decisions at portfolio level. In addition, they will work closely with internal teams and external vendors, communicating plans and results effectively and efficiently, providing guidance to support the program\'s overall success.

Our ideal candidate will have excellent communication and leadership skills, as well as exceptional analytical and strategic abilities. This is an excellent opportunity to join a dynamic team dedicated to the advancement of innovative cancer treatments.

Primary Responsibilities:

Serving as an expert representative for QP2 -IO on Oncology development teams.

Framing critical drug development questions for optimizing model-based developments.

Developing and executing translational PK/PD approaches and population pharmacokinetic modeling by leveraging exposure-response models, clinical trial design simulations, disease progression models, quantitative systems pharmacology (QSP) models, comparator models and other model-based analyses. By continuously using these quantitative tools, they will make informed decisions and drive the pipeline\'s impact.

Strategizing and executing modeling of tumor size and survival endpoints including proportional hazards models.

Maintaining a comprehensive understanding of global regulatory expectations for small molecules and biologics in Oncology area, authoring regulatory documents (investigational new drugs/INDs,

Minimum education required:

Ph.D. with at least seven years of pharmaceutical drug development experience relating to: PKPD, pharmacometrics, mathematics, statistics/ biostatistics, or chemical/biomedical engineering.

Master, PharmD or equivalent degree with at least nine years of experience, where \xe2\x80\x9cexperience\xe2\x80\x9d means having a record of increasing responsibility and independence in a similar role in pharmaceutical drug development.

Required Experience:

Demonstrated impactful experience with applications of pharmacometric methods.

Demonstrated and impactful experience across therapeutic modalities, including ADCs, mAbs, cytokines and small molecules.

Skills in experimental design, mathematical problem solving, critical data analysis/interpretation, and statistics.

An exemplary record of increasing responsibility, independence, and demonstrated impact in driving drug development decisions through application of model-based approaches.

Proficiency in R, NONMEM or other similar programing language.

Proficiency in written and verbal communication.

Authoring clinical study reports, clinical trial applications, various sections of NDA and BLA, and representing QP2 at regulatory meetings.

Mentoring and/or supervising junior staff to perform the above duties and to develop the above capabilities.

NOTICE FOR INTERNAL APPLICANTS

In accordance with all employees subject to this policy are required to have a minimum of twelve (12) months of service in current position prior to applying for open positions.

If you have been offered a separation benefits package, but have not yet reached your separation date and are offered a position within the salary and geographical parameters as set forth in the Summary Plan Description (SPD) of your separationpackage, then you are no longer eligible for your separation benefits package. To discuss in more detail, please contact your HRBP or Talent Acquisition Advisor.

Employees working in roles that the Company determines require routine collaboration with external stakeholders, such as customer-facing commercial, or research-based roles, will be expected to comply not only with Company policy but also with policies established by such external stakeholders (for example, a requirement to be vaccinated against COVID-19 in order to access a facility or meet with stakeholders). Please understand that, as permitted by applicable law, if you have not been vaccinated against COVID-19 and an essential function of your job is to call on external stakeholders who require vaccination to enter their premises or engage in face-to-face meetings, then your employment may pose an undue burden to business operations, in which case you may not be offered employment, or your employment could be terminated. Please also note that, where permitted by applicable law, the Company reserves the right to require COVID-19 vaccinations for positions, such as in Global Employee Health, where the Company determines in its discretion that the nature of the role presents an increased risk of disease transmission.

Current Employees apply

Current Contingent Workers apply

US and Puerto Rico Residents Only:

Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities. Please if you need an accommodation during the application or hiring process.

We are an Equal Opportunity Employer, committed to fostering an inclusive and diverse workplace. All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status, or other applicable legally protected characteristics. For more information about personal rights under the U.S. Equal Opportunity Employment laws, visit:

We are proud to be a company that embraces the value of bringing diverse, talented, and committed people together. The fastest way to breakthrough innovation is when diverse ideas come together in an inclusive environment. We encourage our colleagues to respectfully challenge one another\xe2\x80\x99s thinking and approach problems collectively.

U.S. Hybrid Work Model

Effective September 5, 2023, employees in office-based positions in the U.S. will be working a Hybrid work consisting of three total days on-site per week, generally Tuesday, Wednesday and either Monday or Thursday, although the specific days may vary by site or organization, with Friday designated as a remote-working day, unless business critical tasks require an on-site presence. This Hybrid work model does not apply to, and daily in-person attendance is required for, field-based positions; facility-based, manufacturing-based, or research-based positions where the work to be performed is located at a Company site; positions covered by a collective-bargaining agreement (unless the agreement provides for hybrid work); or any other position for which the Company has determined the job requirements cannot be reasonably met working remotely. Please note, this Hybrid work model guidance also does not apply to roles that have been designated as \xe2\x80\x9cremote\xe2\x80\x9d.

Under New York City, Colorado State, Washington State, and California State law, the Company is required to provide a reasonable estimate of the salary range for this job. Final determinations with respect to salary will take into account a number of factors, which may include, but not be limited to the primary work location and the chosen candidate\xe2\x80\x99s relevant skills, experience, and education.

Expected salary range: $175,440.00 - $276,200.00

Available benefits include bonus eligibility, health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and sick days. For Washington State Jobs, a summary of benefits is listed .

Search Firm Representatives Please Read Carefully
Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails.

Employee Status: Regular

Relocation: Domestic

VISA Sponsorship: Yes

Travel Requirements: 10%

Flexible Work Arrangements: Hybrid

Shift: 1st - Day

Valid Driving License: No

Hazardous Material(s): n/a

Merck & Co.